Speaker

Oct 17-18, 2022    London, UK
3rd International Conference on

Sports Medicine-Fitness and Physiotherapy

Suad Trebinjac

Suad Trebinjac

United Arab Emirates

Title: Regenerative therapy for ligaments, tendons and meniscus injuries. Current evidence

Abstract:

Ligaments, tendons and meniscus are among the most common sports injuries with poor healing potential. Persistent symptoms and limited function have serious impact on sports carrier.Current treatment is mainly limited to symptom relieve which results in chronicity and incomplete healing. Regenerative medicine is evolving medical science offering possibility to shift our scope from “care” to “cure”. In its theoretical concept it brings the hope that impaired tissue can be regenerated and functional as before the injury. The most common form of regenerative therapy in sports medicine is direct injections to the damaged tissue. The ingredients with possible regenerative potential that are recently used are dextrose (the treatment is called prolotherapy), platelet rich plasma (PRP) and mesenchymal stem cells (MSc).By searching the literature and current evidence we will try to answer three important questions related to regeneration of ligaments, tendons and meniscus :

  1. Do regenerative injections provide long term symptoms relieve?
  2. Are there verified structural changes in injected tissues after the treatment?
  3. Does regenerative therapy reduce the time to return to play?

 The future of regenerative medicine based on current research will be elaborated in detail.